Cart
sales@molnova.com
Sotorasib
CAS No. 2252403-56-6
Sotorasib( AMG-510 racemate )
Catalog No. M21832 CAS No. 2252403-56-6
Sotorasib (AMG-510) racemate is the racemate of Sotorasib (AMG-510). AMG-510 is a potent, orally bioavailable, and selective KRAS G12C covalent inhibitor with anti-tumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 28 | In Stock |
|
| 5MG | 43 | In Stock |
|
| 10MG | 69 | In Stock |
|
| 25MG | 142 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 404 | In Stock |
|
| 500MG | 888 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSotorasib
-
NoteResearch use only, not for human use.
-
Brief DescriptionSotorasib (AMG-510) racemate is the racemate of Sotorasib (AMG-510). AMG-510 is a potent, orally bioavailable, and selective KRAS G12C covalent inhibitor with anti-tumor activity.
-
DescriptionSotorasib (AMG-510) racemate is the racemate of Sotorasib (AMG-510). AMG-510 is a potent, orally bioavailable, and selective KRAS G12C covalent inhibitor with anti-tumor activity.
-
In Vitro——
-
In VivoAnimal Model:Female NOD/SCID mice, tumor xenograft model of NCI-H358 cells which harbor KRAS G12C (human NSCLC cell)Dosage:10, 30, 100 mg/kg Administration:Oral gavage (p.o.), QD for 21 d Result:Suppressed the growth of the NCI-H358 tumors in a dose-dependent manner, observed significant tumor regression at 100 mg/kg and 30 mg/kg with tumor growth inhibition of 137% and 126%, respectively.
-
SynonymsAMG-510 racemate
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2252403-56-6
-
Formula Weight560.59
-
Molecular FormulaC??H??F?N?O?
-
Purity>98% (HPLC)
-
SolubilityDMSO : 3.85 mg/mL (6.87 mM; Need ultrasonic)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Karen Rex, et al. Abstract 3090: In vivo characterization of AMG 510 - a potent and selective KRASG12Ccovalent small molecule inhibitor in preclinical KRASG12Ccancer models. Experimental and Molecular Therapeutics.
molnova catalog
related products
-
KRas-IN-1
A chemical fragment hit that binds to K-Ras (G12D) with affinities of 1.3-2 mM.
-
6H05
6H05 is a selective, allosteric inhibitor of oncogenic mutant K-Ras(G12C).
-
1-(4-methansulfinylp...
The compound inhibits Ras function and therefore inhibits the abnormal growth of cells.
